Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytek Biosciences Inc (NQ: CTKB ) 5.200 +0.090 (+1.76%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Cytek Biosciences Inc < Previous 1 2 Next > Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe September 18, 2024 Industry Leaders to Explore Cytek’s Advanced Cell Analysis Solutions at ICCS and ESCCA From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility August 21, 2024 Certification Emphasizes Unwavering Commitment to Quality and Is an Essential Step for U.S. Clinical Market Entry From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm July 30, 2024 Expanding Capabilities and Streamlining Experimental Workflows From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Announces $50 Million Stock Repurchase Program June 06, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference May 30, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire 1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China May 28, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems May 20, 2024 New Enhanced Small Particle (ESP™) Detection Option for Cytek Northern Lights™ and Cytek Aurora™ Systems Expands Capabilities of Small Particle Research From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Reports First Quarter 2024 Financial Results May 08, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe April 30, 2024 Company to Conduct Educational Workshops and Tutorials at CYTO and AAI’s IMMUNOLOGY2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024 April 29, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Names William McCombe Chief Financial Officer March 19, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions March 07, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook February 28, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Participate in Upcoming Investor Conferences February 07, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 February 07, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries January 17, 2024 Cytek’s Cutting-Edge Spectral Flow Cytometry Technology, Specialized Staff, Tools and Solutions Set New Benchmarks for Cell Analysis From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results January 08, 2024 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference December 28, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry December 21, 2023 New System Saves Time and Resources, Improves Efficiency and Accuracy From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to participate in the Piper Sandler 35th Annual Healthcare Conference November 14, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Aurora™ CS System Wins BioTech Breakthrough Award for ‘Cell Sorting Product of the Year’ November 08, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Reports Third Quarter 2023 Financial Results November 07, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Report Third Quarter 2023 Financial Results on November 7, 2023 October 19, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Achieves ISO 13485 Certification at Headquarters September 27, 2023 Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational and Clinical Markets in the United States From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference September 20, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Launches Educational Roadshow Focused on Spectral Flow Cytometry September 14, 2023 The Cytek Reveal Roadshow Will Provide Insights to Accelerate Discoveries – from Basic Science to Highly Complex Assays From Cytek Biosciences, Inc. Via GlobeNewswire Cytek® Biosciences Cell Analysis Solutions Take Center Stage at Upcoming Clinical Conferences in the US and Europe September 20, 2023 Company to Lead Symposiums at ICCS and ESCCA From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to participate in the Morgan Stanley 21st Annual Global Healthcare Conference September 06, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences Appoints Dr. Philippe Busque Senior Vice President of Global Sales & Services August 28, 2023 Sales Organization Enhanced, Platform Organization Created From Cytek Biosciences, Inc. Via GlobeNewswire Cytek Biosciences to Participate in the UBS MedTech, Tools and Genomics Summit August 10, 2023 From Cytek Biosciences, Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
